Technologies
PDF


WARF: P04122US

Contrast Agents That Improve GI Tract Opacification During Abdominal and Pelvic CT Scans


INVENTORS -

Andrew Taylor, Jeffrey Hebert, Thomas Winter

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing improved contrast agents for use during CT imaging of the gastrointestinal tract.
OVERVIEWComputed tomography (CT) uses special X-ray equipment to obtain image data from different angles of the body and generate a cross-sectional image of body tissues and organs. Because CT is a non-invasive procedure that provides detailed, cross-sectional images of all types of tissue, it is a preferred method for diagnosing diseases of the bowel and colon.

Water or a positive, liquid contrast agent is often administered to help the radiologist better visualize the stomach, small bowel, and colon; however, these agents may not adequately distend the distal small bowel or may take too long to opacify the terminal ileum and cecum in patients suspected of having appendicitis.
THE INVENTIONUW-Madison researchers have developed improved contrast agents for use during visualization of the gastrointestinal tract during CT scans. The contrast agents include an iso-osmotic contrast agent that preferably comprises polyethylene glycol (PEG) and electrolytes that make the PEG iso-osmotic. A positive contrast agent, such as an iodine- or barium-based contrast agent, may be added to the PEG.
APPLICATIONS
  • CT imaging of the gastrointestinal tract
KEY BENEFITS
  • Rapidly moves through the GI tract, even in the absence of peristalsis
  • Decreases the time required to prepare patients for CT scans
  • Consistently and rapidly opacifies the terminal ileum and cecum in patients suspected of having appendicitis
  • Requires smaller amounts than current contrast agents, reducing cost and improving patient satisfaction
  • Provides low attenuation
  • Adequately distends the entire small bowel
  • Iso-osmotic contrast agent can be administered at the same time as a positive, intravenous contrast agent
ADDITIONAL INFORMATION
For More Information About the Inventors
Tech Fields
Contact Information
For current licensing status, please contact Jeanine Burmania at jeanine@warf.org or 608-960-9846.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.